Effect of waist circumference on reference intervals of liver-related enzyme tests in apparently healthy adult Mexican Americans, black and white Americans

Clinical Biochemistry

Volumn 40, Issue 3-4, 2007, Pages 206-212

  Samadi, Nasser ^a   Cembrowski, George S ^a   Chan, Julie ^a  

^a Alberta Hospital   (Canada)

Author keywords

ALP; ALT; AST; GGT; LD; Liver enzymes; NHANES III; Obesity; Waist circumference

Indexed keywords

ALANINE AMINOTRANSFERASE; ALKALINE PHOSPHATASE; ALPHA GLUTAMYLTRANSFERASE; ASPARTATE AMINOTRANSFERASE; LACTATE DEHYDROGENASE; LIVER ENZYME; TRANSFERASE; UNCLASSIFIED DRUG;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALKALINE PHOSPHATASE BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CONTROLLED STUDY; DEMOGRAPHY; ENZYME ACTIVITY; ENZYME ASSAY; ETHNICITY; FEMALE; HISPANIC; HUMAN; HUMAN EXPERIMENT; LIVER DISEASE; MALE; NEGRO; NORMAL HUMAN; PRIORITY JOURNAL; REFERENCE VALUE; SEX DIFFERENCE; WAIST CIRCUMFERENCE;

ADULT; AFRICAN AMERICANS; BODY WEIGHTS AND MEASURES; ENZYMES; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HUMANS; LIVER; LIVER DISEASES; MALE; MEXICAN AMERICANS; OBESITY; PROGNOSIS; REFERENCE VALUES;

EID: 33846222880     PISSN: 00099120     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clinbiochem.2006.11.007     Document Type: Article

References (41)

1. Gregg E.W., Cheng Y.J., Cadwell B.L., Imperatore G., Williams D.E., Flegal K.M., et al. Secular trends in cardiovascular disease risk factors according to body mass index in US adults. JAMA 293 (2005) 1868-1874
2. Sturm R. Increases in clinically severe obesity in the United States, 1986-2000. Arch. Intern. Med. 163 (2003) 2146-2148
3. Baskin M.L., Ard J., Franklin F., and Allison D.B. Prevalence of obesity in the United States. Obes. Rev. 6 (2005) 5-7
4. Hedley A.A., Ogden C.L., Johnson C.L., Carroll M.D., Curtin L.R., and Flegal K.M. Prevalence of overweight and obesity among US children, adolescents, and adults, 1999-2002. JAMA 291 (2004) 2847-2850
5. White M.A., Kohlmaier J.R., Varnado-Sullivan P., and Williamson D.A. Racial/ethnic differences in weight concerns: protective and risk factors for the development of eating disorders and obesity among adolescent females. Eat. Weight Disord. 8 (2003) 20-25
6. Bellanger T.M., and Bray G.A. Obesity related morbidity and mortality. J. La State Med. Soc. 157 (2005) [Spec No 1:S42-9; quiz 49]
7. Mulhall B.P., Ong J.P., and Younossi Z.M. Non-alcoholic fatty liver disease: an overview. J. Gastroenterol. Hepatol. 17 (2002) 1136-1143
8. Angulo P., and Lindor K.D. Non-alcoholic fatty liver disease. J. Gastroenterol. Hepatol. 17 (2002) S186-S190
9. Mendez-Sanchez N., Chavez-Tapia N.C., and Uribe M. Obesity and non-alcoholic steatohepatitis. Gac. Med. Mex. 140 (2004) S67-S72
10. Reid AE. Nonalcoholic steatohepatitis. Gastroenterology 121 (2001) 710-723
11. Neovius M., Linne Y., and Rossner S. BMI, waist-circumference and waist-hip-ratio as diagnostic tests for fatness in adolescents. Int. J. Obes. Relat. Metab. Disord. 29 (2005) 163-169
12. Mei Z., Grummer-Strawn L.M., Pietrobelli A., Goulding A., Goran M.I., and Dietz W.H. Validity of body mass index compared with other body-composition screening indexes for the assessment of body fatness in children and adolescents. Am. J. Clin. Nutr. 75 (2002) 978-985
13. Ruhl C.E., and Everhart J.E. Determinants of the association of overweight with elevated serum alanine aminotransferase activity in the United States. Gastroentrology 124 (2003) 71-79
14. Ioannou G.N., Weiss N.S., Kowdley K.V., and Dominitz J.A. Is obesity a risk factor for cirrhosis-related death or hospitalization? A population-based cohort study. Gastroenterology 125 (2003) 1053-1059
15. Ruhl C.E., and Everhart J.E. Determinants of the association of overweight with elevated serum alanine aminotransferase activity in the United States. Gastroenterology 124 (2003) 71-79
16. Omagari K., Kadokawa Y., Masuda J., Egawa I., Sawa T., Hazama H., et al. Fatty liver in non-alcoholic non-overweight Japanese adults: incidence and clinical characteristics. J. Gastroenterol. Hepatol. 17 10 (2002) 1098-1105
17. Janssen I., Heymsfield S.B., Allison D.B., Kotler D.P., and Ross R. Body mass index and waist circumference independently contribute to the prediction of nonabdominal, abdominal subcutaneous, and visceral fat. Am. J. Clin. Nutr. 75 (2002) 683-688
18. Stranges S., Dorn J.M., Muti P., Freudenheim J.L., Farinaro E., Russell M., et al. Body fat distribution, relative weight, and liver enzyme levels: a population-based study. Hepatology 39 (2004) 754-763
19. Tiikkainen M., Bergholm R., Vehkavaara S., Rissanen A., Hakkinen A.M., Tamminen M., et al. Effects of identical weight loss on body composition and features of insulin resistance in obese women with high and low liver fat content. Diabetes 52 (2003) 701-707
20. Ioannou G.N., Weiss N.S., Boyko E.J., Kahn S.E., and Lee S.P. Contribution of metabolic factors to alanine aminotransferase activity in persons with other causes of liver disease. Gastroenterology 128 (2005) 627-635
21. Stranges S., Dorn J.M., Muti P., Freudenheim J.L., Farinaro E., Russell M., Nochajski T.H., and Trevisan M. Body fat distribution, relative weight, and liver enzyme levels: a population-based study. Hepatology 39 (2004) 754-763
22. Grundy S.M., Cleeman J.I., Daniels S.R., Donato K.A., Eckel R.H., and Franklin B.A. Diagnosis and management of the metabolic syndrome. An American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement, Executive Summary. Circulation 112 (2005) e285
23. Okosun IS, Tedders SH, Choi S, Dever GEA. Abdominal adiposity values associated with established body mass indexes in white, black and Hispanic Americans. A study from the Third National Health and Nutrition Examination Survey. Int J Obes 2000;24(10) [p1279, 7p.].
24. Burtis C.A., Ashwood E.R., and Bruns D.E. Tietz Textbook of Clinical Chemistry and Molecular Diagnostics (2006), Elsevier Saunders, St. Louis, MO
25. Clark J.M., Brancati F., and Diehl A.M. Non-alcoholic fatty liver disease: the most common cause of abnormal liver enzymes in the US population. Gastroenterology 120 (2001) A65
26. Caldwell S.H., Harris D.M., Patrie J.T., and Hespenheide E.E. Is NASH underdiagnosed among African Americans?. Am. J. Gastroenterol. 97 (2002) 1496-1500
27. Kemmer N., McKinney K., Xiao S., Singh H., Murray R., Abdo B., et al. High prevalence of nonalcoholic steatohepatitis among Mexican American females with type II diabetes mellitus (abstr). Gastroenterology 120 (2001) A117
28. Ioannou G.N., Weiss N.S., Boyko E.J., Kahn S.E., and Lee S.P. Contribution of metabolic factors to alanine aminotransferase activity in persons with other causes of liver disease. Gastroenterology 128 (2005) 627-635
29. Li T.C., Liu C.S., and Lin C.C. The relationship of liver enzyme abnormalities and obesity in aboriginal children in Taiwan. J. Gastroenterol. 39 (2004) 1170-1174
30. Hoppin A.G. Obesity and the liver: developmental perspectives. Semin. Liver Dis. 24 (2004) 381-387
31. Lam G.M., and Mobarhan S. Central obesity and elevated liver enzymes. Nutr. Rev. 62 (2004) 394-399
32. Lee D.H., Ha M.H., and Christiani D.C. Body weight, alcohol consumption and liver enzyme activity-A 4-year follow-up study. Int. J. Epidemiol. 30 (2001) 766-770
33. Strauss R.S., Barlow S.E., and Dietz W.H. Prevalence of abnormal serum aminotransferase values in overweight and obese adolescents. J. Pediatr. 136 (2000) 727-733
34. Salvaggio A., Periti M., Miano L., Tavanelli M., and Marzorati D. Body mass index and liver enzyme activity in serum. Clin. Chem. 37 (1991) 720-723
35. Burns C.J., Boswell J.M., and Olsen G.W. Liver enzyme activity and body mass index. J. Occup. Environ. Med. 38 (1996) 1248-1252
36. Choi J.W. Association between elevated serum hepatic enzyme activity and total body fat in obese humans. Ann. Clin. Lab. Sci. 33 (2003) 257-264
37. Stranges S., Dorn J.M., Muti P., Freudenheim J.L., Farinaro E., Russell M., et al. Body fat distribution, relative weight, and liver enzyme levels: a population-based study. Hepatology 39 3 (2004) 754-763
38. Clark J.M., Brancati F.L., and Diehl A.M. Nonalcoholic fatty liver disease. Gastroenterology 122 (2002) 1649-1657
39. Navarro V.J., St Louis T., Bell B.Z., and Sofair A.N. Chronic liver disease in the primary care practices of Waterbury, Connecticut. Hepatology 38 (2003) 1062
40. Prati D., Taioli E., Zanella A., Della Torre E., Butelli S., Del Vecchio E., et al. Updated definitions of healthy ranges for serum alanine aminotransferase levels. Ann. Intern. Med. 137 (2002) 1-10
41. Young D. Effects of preanalytical variables on clinical laboratory tests. Ann. Int. Med. 120 (1994) 976